TA is a rare cardiovascular malformation. The single truncal valve shows great morphological variability, with different numbers of leaflets and presenting frequently as dysplastic and insufficient or, more rarely, stenotic[1]. ASV is relatively uncommon, and may manifest as absence of the pulmonary valve, aortic valve, or both[2]. The pathogenesis of ASV is unclear, and best explained by underdevelopment of the endocardial cushion tissue at the ventriculoarterial junction[3]. In addition, genetic or environmental factors, hemodynamic changes, and mesenchymal cells of extracardiac origin derived from neural crest cells might play roles in the occurrence of ASV[4]. The presumed pathogenesis of TA with a dysplastic truncal valve is an insufficient volume of neural crest cells[4]. However, other theories considering the high frequency of combined malformations of the arterial valves and conotruncus suggest a common pathogenesis for these two conditions involving abnormalities of separation of the developing outflow tracts[5]. Recent studies indicated that valvulogenesis is a dynamic and multistep process likely involving many transcription factors and signaling pathways involving members of the TGF-β superfamily, Notch, BMP and GATA families, NFATC1, Wnt/β-catenin, Twist-1, SOX9, and others[6]. These transcription factors and signaling pathways are essential for semilunar valve development.
We identified only one well-documented published case of TA accompanied by ASV that was also diagnosed in the first trimester[7]. We speculate that the reason for the rarity of this condition might be that fetuses with these conditions do not survive the first trimester owing to severe heart failure, similar to fetuses with an absent aortic valve or missing both semilunar valves[8]. In our case, the fetus had systemic edema, abnormal DV blood flow, tricuspid regurgitation, and cardiac enlargement, which might have been manifestations of early heart failure. We believe that with developments in ultrasonographic technology, more similar cases will be detected in the first trimester and the disease spectrum of congenital heart disease will be updated.
TA accompanied by other abnormalities is related to chromosomal abnormalities. The fetus in our case had trisomy 13, and it is the third most common type of aneuploidy after trisomy 21 and trisomy 18, and is associated with congenital heart defects and a poor prognosis[9]. Trisomy 13 may affect the structural integrity of the cardiac system, causing ventricular septal defects, atrial septal defects, patent ductus arteriosus, and other abnormalities. However, to our knowledge, we report the first fetus with trisomy 13 prenatally diagnosed with TA accompanied by ASV.